The prognostic value of Doppler echocardiographic-derived coronary flow reserve is not affected by concomitant antiischemic therapy at the time of testing

American Heart Journal

Volumn 156, Issue 3, 2008, Pages 573-579

  Sicari, Rosa ^a   Rigo, Fausto ^b   Gherardi, Sonia ^c   Galderisi, Maurizio ^d   Cortigiani, Lauro ^e   Picano, Eugenio ^a  

^a INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

^b Umberto I Hospital   (Italy)

^c AUSL Cesena   (Italy)

^d UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^e CAMPO DI MARTE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANGINA PECTORIS AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIPYRIDAMOLE; NITRIC ACID DERIVATIVE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CORONARY ARTERY DISEASE; CORONARY FLOW RESERVE; DOPPLER ECHOCARDIOGRAPHY; DRUG MEGADOSE; FEMALE; HEART INFARCTION; HUMAN; LABORATORY TEST; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; PROGNOSIS; ST SEGMENT ELEVATION; STRESS ECHOCARDIOGRAPHY; SURVIVAL RATE;

ADRENERGIC BETA-ANTAGONISTS; AGED; CALCIUM CHANNEL BLOCKERS; CORONARY ARTERY DISEASE; CORONARY CIRCULATION; ECHOCARDIOGRAPHY, DOPPLER; ECHOCARDIOGRAPHY, STRESS; FEMALE; FOLLOW-UP STUDIES; HEART; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; NITRATES; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES;

EID: 50449088169     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2008.04.016     Document Type: Article

References (36)

1. Sicari R., Cortigiani L., Bigi R., et al. The prognostic value of pharmacological stress echo is affected by concomitant anti-ischemic therapy at the time of testing. Circulation 109 (2004) 2428-2431
2. Hozumi T., Yoshida K., Akasaka T., et al. Noninvasive assessment of coronary flow velocity and coronary flow velocity reserve in the left anterior descending coronary artery by Doppler echocardiography: comparison with invasive technique. J Am Coll Cardiol 32 (1998) 1251-1259
3. Caiati C., Montaldo C., Zedda N., et al. New noninvasive method for coronary flow reserve assessment: contrast-enhanced transthoracic second harmonic echo Doppler. Circulation 99 (1999) 771-778
4. Daimon M., Watanabe H., Yamagishi H., et al. Physiologic assessment of coronary artery stenosis by coronary flow reserve measurements with transthoracic Doppler echocardiography: comparison with exercise thallium-201 single positron emission computed tomography. J Am Coll Cardiol 37 (2001) 1310-1315
5. Saraste M., Koskenvuo J., Knuuti J., et al. Coronary flow reserve: measurement with transthoracic Doppler echocardiography is reproducible and comparable with positron emission tomography. Clin Physiol 21 (2001) 114-122
6. Rigo F., Gherardi S., Galderisi M., et al. The independent prognostic value of contractile and coronary flow reserve determined by dipyridamole stress echocardiography in patients with idiopathic dilated cardiomyopathy. Am J Cardiol 99 (2007) 1154-1158
7. Rigo F., Sicari R., Gherardi S., et al. The additive prognostic value of wall motion abnormalities and coronary flow reserve during dipyridamole stress echo. Eur Heart J 29 (2008) 79-88
8. Rigo F., Cortigiani L., Pasanisi E., et al. The additional prognostic value of coronary flow reserve on left anterior descending artery in patients with negative stress echo by wall motion criteria. A transthoracic vasodilator stress echo study. Am Heart J 149 (2005) 684-689
9. Lattanzi F., Picano E., Bolognese L., et al. Inhibition of dipyridamole-induced ischemia by antianginal therapy in humans. Correlation with exercise echocardiography. Circulation 83 (1991) 1256-1262
10. Billinger M., Seiler C., Fleisch M., et al. Do beta-adrenergic blocking agents increase coronary flow reserve?. J Am Coll Cardiol 38 (2001) 1866-1871
11. Galderisi M., Cicala S., D'Errico A., et al. Nebivolol improves coronary flow reserve in hypertensive patients without coronary heart disease. J Hypertens 22 (2004) 2201-2208
12. Togni M., Vigorito F., Windecker S., et al. Does the beta-blocker nebivolol increase coronary flow reserve?. Cardiovasc Drugs Ther 21 (2007) 99-108
13. Sicari R., Nihoyannopoulos P., Evangelista A., et al. Stress echocardiography expert consensus statement from the European Association of Echocardiography. Eur J Echocardiogr 9 (2008) 415-437
14. Rigo F., Murer B., Ossena G., et al. Transthoracic echocardiographic imaging of coronary arteries: tips, traps, and pitfalls. Cardiovasc Ultrasound 6 (2008) 7
15. Cerqueira M.D., Weissman N.J., Dilsizian V., et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation 105 (2002) 539-542
16. Lang R.M., Bierig M., Devereux R.B., et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 18 (2005) 1440-1463
17. Ciampi Q., and Villari B. Role of echocardiography in diagnosis and risk stratification in heart failure with left ventricular systolic dysfunction. Cardiovasc Ultrasound 5 (2007) 34
18. Picano E., Mathias Jr. W., Pingitore A., et al. Safety and tolerability of dobutamine-atropine stress echocardiography: a prospective, multicentre study. Echo Dobutamine International Cooperative Study Group. Lancet 344 (1994) 1190-1192
19. Lauer M.S., Blackstone E.H., Young J.B., et al. Cause of death in clinical research: time for a reassessment. J Am Coll Cardiol 34 (1999) 618-620
20. Gibler W.B., Cannon C.P., Blomkalns A.L., et al. Practical implementation of the guidelines for unstable angina/non-ST-segment elevation myocardial infarction in the emergency department: a scientific statement from the American Heart Association Council on Clinical Cardiology (Subcommittee on Acute Cardiac Care), Council on Cardiovascular Nursing, and Quality of Care and Outcomes Research Interdisciplinary Working Group, in Collaboration With the Society of Chest Pain Centers. Circulation 111 (2005) 2699-2710
21. Sicari R., Pasanisi E., Venneri L., et al. Stress echo results predict mortality: a large-scale multicenter prospective international study. J Am Coll Cardiol 41 (2003) 589-595
22. Marwick T.H., Case C., Sawada S., et al. Prediction of mortality using dobutamine echocardiography. J Am Coll Cardiol 37 (2001) 754-760
23. Fox K., Garcia M.A., Ardissino D., et al. Guidelines on the management of stable angina pectoris: executive summary. The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology. Eur Heart J 27 (2006) 1341-1381
24. San Román J.A., Vilacosta I., Castillo J.A., et al. Dipyridamole and dobutamine-atropine stress echocardiography in the diagnosis of coronary artery disease. Comparison with exercise stress test, analysis of agreement, and impact of antianginal treatment. Chest 110 (1996) 1248-1254
25. Ferrara N., Coltorti F., Leosco D., et al. Protective effect of beta-blockade on dipyridamole-induced myocardial ischemia. Role of heart rate. Eur Heart J 16 (1995) 903-908
26. Ferrara N., Longobardi G., Nicolino A., et al. Effect of beta-adrenoceptor blockade on dipyridamole-induced myocardial asynergies in coronary artery disease. Am J Cardiol 70 (1992) 724-727
27. Fioretti P.M., Poldermans D., Salustri A., et al. Atropine increases the accuracy of dobutamine stress echocardiography in patients taking beta-blockers. Eur Heart J 15 (1994) 355-360
28. Erdogan D., Gullu H., Caliskan M., et al. Nebivolol improves coronary flow reserve in patients with idiopathic dilated cardiomyopathy. Heart 93 (2006) 319-324
29. Cortigiani L., Rigo F., Gherardi S., et al. Additional prognostic value of coronary flow reserve in diabetic and nondiabetic patients with negative dipyridamole stress echocardiography by wall motion criteria. J Am Coll Cardiol 50 (2007) 1354-1361
30. Beller G.A., and Gibson R.S. Sensitivity and specificity and prognostic significance of non-invasive testing for occult or known coronary disease. Prog Cardiovasc Dis 29 (1987) 241-270
31. Taillefer R., Ahlberg A.W., Masood Y., et al. Acute beta-blockade reduces the extent and severity of myocardial perfusion defects with dipyridamole Tc-99 m sestamibi SPECT imaging. J Am Coll Cardiol 42 (2003) 1475-1483
32. Ferrara N., Coltorti F., Leosco D., et al. Protective effect of beta-blockade on dipyridamole-induced myocardial ischaemia. Role of heart rate. Eur Heart J 16 (1995) 903-908
33. Gibbons R.J., Abrams J., Chatterjee K., et al. ACC/AHA 2002 guideline update for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for the management of Patients with Chronic Stable Angina. Circulation 107 (2003) 149-158
34. Phillips K.A., Shlipak M.G., Coxson P., et al. Health and economic benefits of increased beta-blocker use following myocardial infarction. JAMA 284 (2000) 2748-2754
35. L'Abbate A. Large and micro coronary vascular involvement in diabetes. Pharmacol Rep 57 Suppl (2005) 3-9
36. Picano E., and Sicari R. Risk stratification by stress echocardiography: a whiter shade of pale. Eur J Echocardiogr 5 (2004) 162-164